World's Best Scientists 2026 revealed!

Overview

Alan J. Garber was affiliated with Baylor College of Medicine in the United States. Their research primarily focused on the field of Medicine, with a significant concentration in Endocrinology, Diabetes and Metabolism. Other areas of study included Surgery and Economics and Econometrics.

They contributed to the understanding and management of diabetes and cardiovascular health through their research on topics such as:

  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Systems, Economic Evaluations, Quality of Life

Alan J. Garber's recent scholarly output includes publications in the journal Endocrine Practice. Their notable papers were:

  • Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2020 Executive Summary (2020)
  • Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary (2020)

The scientist frequently collaborated with several colleagues, including:

  • Yehuda Handelsman
  • George Grunberger
  • Daniel Einhorn
  • Paul S. Jellinger
  • Jeffrey I. Mechanick

Throughout their career, Alan J. Garber contributed to advancing knowledge related to diabetes care algorithms, lipid management, and cardiovascular disease prevention protocols. Their research appeared predominantly in Endocrine Practice, indicating a consistent focus on clinical endocrinology topics.

Best Publications

  • Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Alan Garber;Robert Henry;Robert Ratner;Pedro A Garcia-Hernandez

  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.

    W. Timothy Garvey;Jeffrey I. Mechanick;Elise M. Brett;Alan J. Garber

  • STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/ AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL

    Helena W. Rodbard;Paul S. Jellinger;Jaime A. Davidson;Daniel Einhorn

  • AACE comprehensive diabetes management algorithm 2013.

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

    Paul S. Jellinger;Yehuda Handelsman;Paul D. Rosenblit;Zachary T. Bloomgarden

  • Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

    Philip Raskin;Elsie Allen;Priscilla Hollander;Andrew Lewin

  • American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

    Yehuda Handelsman;Zachary T. Bloomgarden;George Grunberger;Guillermo Umpierrez

  • American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary

    Yehuda Handelsman;Jeffrey I. Mechanick;Lawrence Blonde;George Grunberger

  • American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan

    Yehuda Handelsman;Jeffrey Mechanick;Lawrence Blonde;George Grunberger

  • Efficacy of Metformin in Type II Diabetes: Results of a Double-Blind, Placebo-controlled, Dose-Response Trial

    Alan J. Garber;Theodore G. Duncan;Anita M. Goodman;Donna J. Mills

  • Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

    Emanuele Bosi;Riccardo Paolo Camisasca;Carole Collober;Erika Rochotte

  • American College of Endocrinology position statement on inpatient diabetes and metabolic control.

    Alan J Garber;Etie S Moghissi;Edwin D Bransome;Nathaniel G Clark

  • The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone.

    Ralph A. DeFronzo;Miguel N. Hissa;Alan J. Garber;Jorge Luiz Gross

  • CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.

    Alan J. Garber;Yehuda Handelsman;George Grunberger;Daniel Einhorn

  • Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Joshua I. Barzilay;Lawrence Blonde

  • CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man.

    A J Garber;P E Cryer;J V Santiago;M W Haymond

  • Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

    Alan J Garber;Allen B King;Stefano Del Prato;Seamus Sreenan

  • Long-Acting Glucagon-Like Peptide 1 Receptor Agonists

    Alan J. Garber

Frequent Co-Authors

W. Timothy Garvey
W. Timothy Garvey University of Alabama at Birmingham
Irl B. Hirsch
Irl B. Hirsch University of Washington
Guillermo E. Umpierrez
Guillermo E. Umpierrez Emory University
Janet B. McGill
Janet B. McGill Washington University in St. Louis
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
Vivian Fonseca
Vivian Fonseca Tulane University
Michael H. Davidson
Michael H. Davidson University of Chicago
Edward S. Horton
Edward S. Horton Harvard Medical School
Lutz Birnbaumer
Lutz Birnbaumer National Institutes of Health
Robert R. Henry
Robert R. Henry University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare but not sure medical school is right for you, there are many other promising online options. The growing demand for skilled health professionals has expanded affordable, flexible ways to enter the field.

For those interested in managing patient data, pursuing a him degree online can lead to careers in health information management, records analysis, or data security. Another popular pathway is billing and coding classes online, which prepare graduates for essential administrative roles in hospitals, clinics, and insurance companies.

Nursing remains a high-demand profession with many online entry points. You can explore cheap online fnp programs if you have a nursing background and want to become a Family Nurse Practitioner, or consider affordable nursing programs online to become an RN or advance your credentials.

Each of these pathways offers flexibility, lower tuition costs, and great career potential in the dynamic U.S. healthcare system.

Best Scientists Citing Alan J. Garber